SNHG15 is a negative regulator of inflammation by mediating TRAF2 ubiquitination in stroke-induced immunosuppression

Abstract Background Abnormal expression of long noncoding RNAs (lncRNAs) has been reported in the acute stage of acute ischemic stroke (AIS). This study aimed to explore differential lncRNA expression in the subpopulations of peripheral blood mononuclear cells (PBMCs) from AIS patients and further e...

Full description

Bibliographic Details
Main Authors: Huiling Sun, Shuo Li, Zhaohan Xu, Chengfang Liu, Pengyu Gong, Qiwen Deng, Fuling Yan
Format: Article
Language:English
Published: BMC 2022-01-01
Series:Journal of Neuroinflammation
Subjects:
Online Access:https://doi.org/10.1186/s12974-021-02372-z
_version_ 1818964019968475136
author Huiling Sun
Shuo Li
Zhaohan Xu
Chengfang Liu
Pengyu Gong
Qiwen Deng
Fuling Yan
author_facet Huiling Sun
Shuo Li
Zhaohan Xu
Chengfang Liu
Pengyu Gong
Qiwen Deng
Fuling Yan
author_sort Huiling Sun
collection DOAJ
description Abstract Background Abnormal expression of long noncoding RNAs (lncRNAs) has been reported in the acute stage of acute ischemic stroke (AIS). This study aimed to explore differential lncRNA expression in the subpopulations of peripheral blood mononuclear cells (PBMCs) from AIS patients and further evaluate its underlying mechanisms in stroke-induced immunosuppression. Methods We reanalyzed lncRNA microarray data and investigated abnormally expressed lncRNAs in the subpopulations of PBMCs by magnetic cell sorting and real-time quantitative PCR. The potential mechanism of small nucleolar RNA host gene 15 (SNHG15) was explored through in vitro and in vivo approaches. Results The stroke-induced SNHG15 acted as a checkpoint to inhibit peripheral inflammatory responses. Functional studies showed that SNHG15 promoted M2 macrophage polarization. Mechanistically, SNHG15 expression was dysregulated through the Janus kinase (JAK)-signal transducer and activator of transcription 6 (STAT6) signaling pathway. SNHG15, localized in the cytoplasm, interfered with K63-linked ubiquitination of tumor necrosis factor receptor-associated factor 2 and thereby repressed the activation of mitogen-activated protein kinase and nuclear factor kappa-B signaling pathways and prevented the production of proinflammatory cytokines. Administration of an adenovirus targeting SNHG15 improved stroke-induced immunosuppression in mice. Conclusions This study identified SNHG15 as a negative regulator of inflammation in stroke-induced immunosuppression, suggesting it as a novel biomarker and therapeutic target in stroke-associated infection. Trial registration ClinicalTrials.gov NCT04175691. Registered November 25, 2019, https://www.clinicaltrials.gov/ct2/show/NCT04175691 .
first_indexed 2024-12-20T12:54:28Z
format Article
id doaj.art-0c66b96b734a4763a009b452b5bb8393
institution Directory Open Access Journal
issn 1742-2094
language English
last_indexed 2024-12-20T12:54:28Z
publishDate 2022-01-01
publisher BMC
record_format Article
series Journal of Neuroinflammation
spelling doaj.art-0c66b96b734a4763a009b452b5bb83932022-12-21T19:40:05ZengBMCJournal of Neuroinflammation1742-20942022-01-0119111510.1186/s12974-021-02372-zSNHG15 is a negative regulator of inflammation by mediating TRAF2 ubiquitination in stroke-induced immunosuppressionHuiling Sun0Shuo Li1Zhaohan Xu2Chengfang Liu3Pengyu Gong4Qiwen Deng5Fuling Yan6General Clinical Research Center, Nanjing First Hospital, Nanjing Medical UniversityDepartment of Neurology, Affiliated ZhongDa Hospital, School of Medicine, Southeast UniversityDepartment of Neurology, Nanjing First Hospital, Nanjing Medical UniversityDepartment of Neurology, Nanjing First Hospital, Nanjing Medical UniversityDepartment of Neurology, Nanjing First Hospital, Nanjing Medical UniversityDepartment of Neurology, Nanjing First Hospital, Nanjing Medical UniversityDepartment of Neurology, Affiliated ZhongDa Hospital, School of Medicine, Southeast UniversityAbstract Background Abnormal expression of long noncoding RNAs (lncRNAs) has been reported in the acute stage of acute ischemic stroke (AIS). This study aimed to explore differential lncRNA expression in the subpopulations of peripheral blood mononuclear cells (PBMCs) from AIS patients and further evaluate its underlying mechanisms in stroke-induced immunosuppression. Methods We reanalyzed lncRNA microarray data and investigated abnormally expressed lncRNAs in the subpopulations of PBMCs by magnetic cell sorting and real-time quantitative PCR. The potential mechanism of small nucleolar RNA host gene 15 (SNHG15) was explored through in vitro and in vivo approaches. Results The stroke-induced SNHG15 acted as a checkpoint to inhibit peripheral inflammatory responses. Functional studies showed that SNHG15 promoted M2 macrophage polarization. Mechanistically, SNHG15 expression was dysregulated through the Janus kinase (JAK)-signal transducer and activator of transcription 6 (STAT6) signaling pathway. SNHG15, localized in the cytoplasm, interfered with K63-linked ubiquitination of tumor necrosis factor receptor-associated factor 2 and thereby repressed the activation of mitogen-activated protein kinase and nuclear factor kappa-B signaling pathways and prevented the production of proinflammatory cytokines. Administration of an adenovirus targeting SNHG15 improved stroke-induced immunosuppression in mice. Conclusions This study identified SNHG15 as a negative regulator of inflammation in stroke-induced immunosuppression, suggesting it as a novel biomarker and therapeutic target in stroke-associated infection. Trial registration ClinicalTrials.gov NCT04175691. Registered November 25, 2019, https://www.clinicaltrials.gov/ct2/show/NCT04175691 .https://doi.org/10.1186/s12974-021-02372-zLong noncoding RNAIschemic strokeSNHG15ImmunosuppressionTRAF2
spellingShingle Huiling Sun
Shuo Li
Zhaohan Xu
Chengfang Liu
Pengyu Gong
Qiwen Deng
Fuling Yan
SNHG15 is a negative regulator of inflammation by mediating TRAF2 ubiquitination in stroke-induced immunosuppression
Journal of Neuroinflammation
Long noncoding RNA
Ischemic stroke
SNHG15
Immunosuppression
TRAF2
title SNHG15 is a negative regulator of inflammation by mediating TRAF2 ubiquitination in stroke-induced immunosuppression
title_full SNHG15 is a negative regulator of inflammation by mediating TRAF2 ubiquitination in stroke-induced immunosuppression
title_fullStr SNHG15 is a negative regulator of inflammation by mediating TRAF2 ubiquitination in stroke-induced immunosuppression
title_full_unstemmed SNHG15 is a negative regulator of inflammation by mediating TRAF2 ubiquitination in stroke-induced immunosuppression
title_short SNHG15 is a negative regulator of inflammation by mediating TRAF2 ubiquitination in stroke-induced immunosuppression
title_sort snhg15 is a negative regulator of inflammation by mediating traf2 ubiquitination in stroke induced immunosuppression
topic Long noncoding RNA
Ischemic stroke
SNHG15
Immunosuppression
TRAF2
url https://doi.org/10.1186/s12974-021-02372-z
work_keys_str_mv AT huilingsun snhg15isanegativeregulatorofinflammationbymediatingtraf2ubiquitinationinstrokeinducedimmunosuppression
AT shuoli snhg15isanegativeregulatorofinflammationbymediatingtraf2ubiquitinationinstrokeinducedimmunosuppression
AT zhaohanxu snhg15isanegativeregulatorofinflammationbymediatingtraf2ubiquitinationinstrokeinducedimmunosuppression
AT chengfangliu snhg15isanegativeregulatorofinflammationbymediatingtraf2ubiquitinationinstrokeinducedimmunosuppression
AT pengyugong snhg15isanegativeregulatorofinflammationbymediatingtraf2ubiquitinationinstrokeinducedimmunosuppression
AT qiwendeng snhg15isanegativeregulatorofinflammationbymediatingtraf2ubiquitinationinstrokeinducedimmunosuppression
AT fulingyan snhg15isanegativeregulatorofinflammationbymediatingtraf2ubiquitinationinstrokeinducedimmunosuppression